Skip to main content

Biolife Solutions Inc

BLFS
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0000834365

No open-market purchases or sales by Biolife Solutions Inc insiders were filed in the last 90 days; 216 institutions reported holding it in 13F filings for Q2 2026, worth $1.40B in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding Biolife Solutions Inc changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of BLFS: Q3 2023 compared with Q4 2023
MeasureQ3 2023Of which not filed for Q4 2023Q4 2023Change
Holders1533140−10
Shares43.6M37.8K45.4M+1.85M (+4.3%)
Value$601.8M$521.9K$737.7M+$136.4M (+22.7%)

3 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (14)

Institutions that held Biolife Solutions Inc at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to BLFS in Q4 2023
InstitutionSharesValue% of portfolio
Portolan Capital Management, LLC521,906$8.48M0.74%
Polar Asset Management Partners Inc.241,600$3.93M0.11%
Caption Management, LLC32,500$528.1K0.06%
Cerity Partners LLC26,941$437.8K0.00%
Pathstone Holdings, LLC21,352$347.0K0.00%
Landscape Capital Management, L.L.C.18,629$302.7K0.03%
Campbell & CO Investment Adviser LLC14,680$238.6K0.02%
Entropy Technologies, LP11,123$180.7K0.03%
Connors Investor Services Inc10,200$166.0K0.02%
GAMMA Investing LLC2,394$40.7K0.01%
Pineridge Advisors LLC436$7.08K0.00%
Farther Finance Advisors, LLC382$6.21K0.00%
Smartleaf Asset Management LLC154$2.57K0.00%
SYSTM Wealth Solutions LLC23$3740.00%

Sold out (24)

Institutions that held Biolife Solutions Inc at the end of Q3 2023 and filed for Q4 2023 without it.

Not filed for Q4 2023 yet (3)

Institutions that held Biolife Solutions Inc at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding BLFS in Q3 2023 that haven't filed for Q4 2023
InstitutionShares, Q3 2023Value, Q3 2023
Pathstone Family Office, LLC21,605$298.4K
First Republic Investment Management, Inc.11,186$154.5K
Kenfarb & Co.5,000$69.0K